The federal authorities is halting a $765 million mortgage to Eastman Kodak Corporation for its generic drug-building foray right until the business is cleared of insider investing allegations.
“On July 28, we signed a Letter of Curiosity with Eastman Kodak. Current allegations of wrongdoing elevate serious fears,” the United States Intercontinental Growth Finance Company explained in a assertion late Friday. “We will not move forward any further except if these allegations are cleared.”
The impartial federal agency had signed a letter of intent with the previous images large for the mortgage, which was to be utilised to make prescription drugs